ArticleNature neuroscience2026
SIK3 controls synaptic localization of NMDA receptors by phosphorylating GluN1.
Article in Nature neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synaptic NMDA-type glutamate receptors (NMDARs) are central components of all neural computations. NMDAR levels critically vary between synapses but how the synaptic localization of NMDARs is controlled remains unclear. Here we show that SIK3, a serine-threonine protein kinase, localizes to synapses where it phosphorylates the obligatory NMDAR subunit GluN1 at a single site. This single phosphorylation event controls NMDAR recruitment to synapses. Genetic deletion of SIK3 severely and selectively decreases synaptic GluN1 levels by ~60% without altering AMPA-type glutamate receptor levels or inducing major transcriptional changes. Pharmacological inhibition of SIK3 impairs synaptic NMDAR responses within 45 minutes. Mutating the SIK3-phosphorylation site inhibits GluN1 synaptic recruitment. 'Sleepy', a gain-of-function mutation in SIK3 that increases sleep, selectively enhances synaptic NMDAR levels by increasing GluN1 phosphorylation. Thus, SIK3 phosphorylation of GluN1 provides a key signal for recruiting NMDARs to synapses.
Identifiers
42907494What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.